RECURRENT LOW-GRADE GLIOMA
Clinical trials for RECURRENT LOW-GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LOW-GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT LOW-GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with brain tumors: drug that crosses the Blood-Brain barrier shows promise
Disease control Recruiting nowThis study is testing a drug called mirdametinib in children, adolescents, and young adults with low-grade glioma, a type of brain tumor. The drug is designed to reach the brain and block signals that help tumors grow. The goal is to find the best dose and see if it can shrink tu…
Matched conditions: RECURRENT LOW-GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 16, 2026 22:27 UTC
-
Laser zaps brain tumors in kids: new hope for recurrent Low-Grade glioma
Disease control Recruiting nowThis study tests a laser treatment called LITT for children, teens, and young adults whose low-grade brain tumors have come back or worsened after prior therapy. The goal is to stop tumor growth for at least 15 months. About 40 participants will receive the laser procedure, which…
Matched conditions: RECURRENT LOW-GRADE GLIOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Can brain tumor patients safely reduce their medication? new study investigates
Disease control Recruiting nowThis study looks at whether people with a slow-growing brain tumor (low-grade glioma) that has a specific gene change (BRAF V600) can safely stop or lower their dose of two targeted drugs (dabrafenib and trametinib) after taking them for 12-24 months. About 96 participants will e…
Matched conditions: RECURRENT LOW-GRADE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 13, 2026 16:02 UTC